Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
Enrolling by invitation · NCT06868459 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry | Head and Neck Neoplasms, Neoplasms by Site, Thyroid Nodule, endocrine system disorder, goiter, hyperthyroidism, malignant endocrine neoplasm, multinodular goiter, neoplasm, thyroid gland disorder, thyroid tumor | Enrolling by invitation | Not stated | 2026-09-30 | NCT06868459 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sarasota Memorial Health Care System | 8 |
| TriSalus Life Sciences, Inc. | 7 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University School of Medicine | Atlanta | United States | 47 |
| Mayo Clinic | Jacksonville | United States | 122 |
| Sarasota Memorial Health Care System | Sarasota | United States | 20 |
| Tulane University School of Medicine | New Orleans | United States | 47 |